Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

United Community Banks Exceeds Earnings Expectations but Falls Short on Sales

Elaine Mendonca by Elaine Mendonca
January 24, 2024
in Breaking News
0
Banking Trading online
0
SHARES
8
VIEWS
Share on FacebookShare on Twitter

On January 24, 2024, United Community Banks (NASDAQ: UCBI) announced their quarterly earnings, exceeding expectations with earnings of $0.53 per share, surpassing the analyst consensus estimate of $0.52 by 1.92 percent. This indicates a decline of 29.33 percent compared to the earnings of $0.75 per share reported in the corresponding period last year.

Furthermore, the company disclosed their quarterly sales of $180.36 million, falling short of the analyst consensus estimate of $226.07 million by 20.22 percent. This represents a decrease of 25.85 percent in comparison to the sales of $243.24 million during the same period last year.

For further details and comprehensive information, kindly visit the official investor relations website of the company or refer to trusted financial news sources.

United Community Banks, Inc. (UCBI) Stock Price Shows Stability and Potential for Long-Term Growth

On January 24, 2024, United Community Banks, Inc. (UCBI) experienced a slight drop in its stock price. The stock closed at $29.10, marking a decrease of $0.59 or 1.99% since the previous market close. UCBI remains in a relatively stable position in terms of its price momentum.

UCBI is trading in the middle of its 52-week range, indicating stability and suggesting that its stock price has not been subject to extreme fluctuations.

UCBI is trading above its 200-day simple moving average, which suggests that the stock’s price is generally on an upward trajectory over the long term. This is a positive signal for UCBI.

The decline of 1.99% on January 24 is relatively small and may not be indicative of a significant trend. After-hours trading showed no change in the stock price, suggesting that investors are not reacting strongly to the drop.

Overall, UCBI remains in a stable position. Investors should continue to monitor the stock’s performance for any potential trends or changes.

UCBI Stock Performance on January 24, 2024: Positive and Negative Indicators

UCBI Stock Performance on January 24, 2024:

Total revenue: $941.67 million over the past year, representing a 27.44% increase compared to the previous year.

Total revenue from the third quarter: $354.15 million, a 6.76% increase compared to the previous quarter.

Net income: $276.01 million over the past year, remaining flat compared to the previous year.

Net income from the third quarter: $47.61 million, a 24.37% decrease compared to the previous quarter.

Earnings per share (EPS): $2.52 over the past year, a 15.01% decrease compared to the previous year.

EPS from the third quarter: $0.39, a 26.0% decrease compared to the previous quarter.

In conclusion, UCBI’s stock performance on January 24, 2024, exhibited a mix of positive and negative indicators. While their total revenue increased by 27.44% over the past year, the rate of growth slowed down compared to the previous year. The net income remained flat since last year, and a significant decline was observed in the most recent quarter. The earnings per share also experienced declines both on a yearly and quarterly basis. Investors should closely monitor these financial metrics to gain a comprehensive understanding of UCBI’s financial health and make informed decisions regarding their investment in UCBI stock.

Tags: UCBI
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_ Stock Charts (2)

Analyst Upgrades StoneCo Stock to Neutral with 23 Price Target

Finance_ projections

SciSparc Ltd Secures 20 Million Standby Equity Purchase Agreement with YA II PN Ltd for Accelerated Growth and Expansion

Johnson Johnson Reports Strong Financial Results and Addresses Concerns

Recommended

Alphabet Stock

Alphabet Shares Face Regulatory Headwinds Despite Autonomous Driving Breakthrough

4 months ago
Dish Network Stock

Institutional Investors Show Diverging Views on Dish Network’s Future

7 months ago
Finance_ Trading ratings today (2)

Lakeland Financial Exceeds Expectations with Fourth Quarter Earnings

2 years ago
DeFi Technologies Stock

DeFi Technologies: Navigating Expansion Amidst Legal Headwinds

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Hain Celestial Sheds Snack Division in Strategic Overhaul

Technology Sector Faces Mounting Headwinds as AI Hype Meets Macroeconomic Reality

Lumen’s AI Infrastructure Push Gains Recognition Amid Strategic Overhaul

Microsoft’s AI Ambitions Strain Finances as Cash Reserves Shrink

Trending

BioNano Genomics Stock
Analysis

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

by Kennethcix
March 25, 2026
0

BioNano Genomics has wrapped up its fiscal year 2025, presenting a financial picture marked by significant operational...

Humacyte Stock

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

March 25, 2026
Evolent Health Stock

Evolent Health Bets on AI Leadership Amid Share Price Decline

March 25, 2026
MongoDB Stock

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

March 25, 2026
Talphera Stock

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds
  • Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts
  • Evolent Health Bets on AI Leadership Amid Share Price Decline

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com